Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.
about
Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PETHydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.Development of a radiolabeled caninized anti-EGFR antibody for comparative oncology trials.A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Targeting HER2 in Nuclear Medicine for Imaging and Therapy.
P2860
Q33757834-39561C86-13E8-42B3-90E6-2CC16EABEBBDQ37202324-A4FB4140-036A-44CA-A8F1-B8AE5D5E38ECQ37560052-9C856A52-90FF-48A6-8E60-8C31DE20490EQ37631557-FA525B86-8F03-4004-B011-DCAB82CC29BFQ37718007-EDCF9BED-A8FC-4D96-A2AB-FC0A7C9F401DQ38880203-77868BD0-681E-488C-B333-9A36E25E9903Q41690954-359D698B-E6F3-4FD7-BE99-A939D39256ACQ46597771-D30FBD94-F3D6-4113-B260-90F4519CB929Q48118923-3B83A92D-BBF1-467F-A1BA-B1D9A91AE164Q48136353-B9B98A8A-B20C-428F-A921-66FB92141132Q49700421-E1DF328A-30DC-47AE-9618-3A4172C50FDE
P2860
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@ast
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@en
type
label
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@ast
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@en
prefLabel
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@ast
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@en
P2093
P2860
P356
P1433
P1476
Evaluation of a 3-hydroxypyrid ...... of Ovarian Carcinoma in Mice.
@en
P2093
Alexander N Vanderbilt
Annie Ogasawara
Darren Magda
Herman S Gill
Jeff N Tinianow
Simon-P Williams
Thaddeus J Wadas
P2860
P304
P356
10.7150/THNO.14261
P577
2016-02-13T00:00:00Z